Cargando…

Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1

OBJECTIVE: Inhibition of tumor metastasis is a useful strategy to improve the efficacy of cancer therapy. Ventilagolin, a natural 1, 4-naphthoquinone derivative extracted from Ventilago leiocarpa Benth, has shown promising antitumor effects in previous studies. However, the effects and underlying me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ying, Cheng, Dao-Hai, Lai, Ke-Dao, Su, Hua, Lu, Guo-Shou, Wang, Li, Lv, Ji-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647656/ https://www.ncbi.nlm.nih.gov/pubmed/34880599 http://dx.doi.org/10.2147/DDDT.S327270

Ejemplares similares

Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma
por: Lee, Jong Hyun, et al.
Publicado: (2020)

Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer
por: Su, Bo, et al.
Publicado: (2016)

Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway
por: Liu, Qian-Qian, et al.
Publicado: (2016)

Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial–mesenchymal transition
por: Wang, Nanyao, et al.
Publicado: (2016)

Plectin Downregulation Inhibits Migration and Suppresses Epithelial Mesenchymal Transformation of Hepatocellular Carcinoma Cells via ERK1/2 Signaling
por: Xu, Rushuang, et al.
Publicado: (2022)

Shikonin suppresses the epithelial-to-mesenchymal transition by downregulating NHE1 in bladder cancer cells
por: Mo, Lijun, et al.
Publicado: (2021)

FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition
por: Zhang, Xiang, et al.
Publicado: (2019)

Downregulation of PIM1 regulates glycolysis and suppresses tumor progression in gallbladder cancer
por: Xue, Chen, et al.
Publicado: (2018)

Disabled-2 downregulation promotes epithelial-to-mesenchymal transition
por: Martin, J C, et al.
Publicado: (2010)

Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8
por: Ji, Shufang, et al.
Publicado: (2016)

PTEN suppresses epithelial–mesenchymal transition and cancer stem cell activity by downregulating Abi1
por: Qi, Yanmei, et al.
Publicado: (2020)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

ECM1 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition
por: Chen, Hao, et al.
Publicado: (2016)

Downregulation of PIM1 Regulates Glycolysis and Suppresses Tumor Progression in Gallbladder Cancer [Retraction]
Publicado: (2023)

miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion
por: Chen, Dahu, et al.
Publicado: (2014)

FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition
por: Ogunbolude, Yetunde, et al.
Publicado: (2017)

Downregulation of lncRNA PVT1 expression inhibits proliferation and migration by regulating p38 expression in prostate cancer
por: Wan, Bo, et al.
Publicado: (2018)

MiR‐30c protects diabetic nephropathy by suppressing epithelial‐to‐mesenchymal transition in db/db mice
por: Zhao, Yanru, et al.
Publicado: (2017)

Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1
por: Cha, Byong-Ki, et al.
Publicado: (2016)

FOXN2 is downregulated in breast cancer and regulates migration, invasion, and epithelial– mesenchymal transition through regulation of SLUG
por: Ye, Hui, et al.
Publicado: (2019)

Downregulation of FOXO6 in breast cancer promotes epithelial–mesenchymal transition and facilitates migration and proliferation of cancer cells
por: Ye, Hui, et al.
Publicado: (2018)

Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
por: Liu, Jingmei, et al.
Publicado: (2023)

Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer
por: Uddin, Nizam, et al.
Publicado: (2015)

Emodin Inhibits Colon Cancer Cell Invasion and Migration by Suppressing Epithelial–Mesenchymal Transition via the Wnt/β-Catenin Pathway
por: Gu, Juan, et al.
Publicado: (2019)

Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4
por: Li, Qi, et al.
Publicado: (2016)

Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2018)

NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition
por: Zhang, Yi, et al.
Publicado: (2018)

ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition
por: Ye, Zhiyu, et al.
Publicado: (2018)

Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial–mesenchymal transition in triple‐negative breast cancer
por: Lv, Zhi‐Dong, et al.
Publicado: (2016)

Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9
por: Yang, Feilong, et al.
Publicado: (2018)

SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration
por: Eguchi, Takanori, et al.
Publicado: (2022)

Human Surfactant Protein D Suppresses Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells by Downregulating TGF-β
por: Kaur, Anuvinder, et al.
Publicado: (2018)

Downregulation of Immortalization-Upregulated Protein Suppresses the Progression of Breast Cancer Cell Lines by Regulating Epithelial–Mesenchymal Transition
por: Wen, Jialiang, et al.
Publicado: (2020)

Cyclin F Downregulation Affects Epithelial-Mesenchymal Transition Increasing Proliferation and Migration of the A-375 Melanoma Cell Line
por: Krajewski, Adrian, et al.
Publicado: (2020)

Downregulation of DOCK1 sensitizes bladder cancer cells to cisplatin through preventing epithelial–mesenchymal transition
por: Chen, Da-jin, et al.
Publicado: (2016)

Collective and Individual Migration following the Epithelial-Mesenchymal Transition
por: Wong, Ian Y., et al.
Publicado: (2014)

MiR-23b-3p suppresses epithelial-mesenchymal transition, migration, and invasion of hepatocellular carcinoma cells by targeting c-MET
por: Park, Na Ri, et al.
Publicado: (2022)

Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition
por: Banno, Asoka, et al.
Publicado: (2016)

Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation
por: Dong, Shuying, et al.
Publicado: (2015)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3svld48gltfakth6hjgvuk68jn